Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Mark Doherty

Showing results (41-50 of 91) with videos related to

Pageof 10
Sort By:
Vaccine|May 23, 2009
Vaccines in a hurryChristian Søborg, Kåre Mølbak, T Mark Doherty, et al.
Lancet (London, England)|May 22, 2010
Biomarkers and diagnostics for tuberculosis: progress, needs, and translation into practiceRobert S Wallis, Madhukar Pai, Dick Menzies, et al.
Infection and Immunity|April 20, 2006
The 6-kilodalton early secreted antigenic target-responsive, asymptomatic contacts of tuberculosis patients express elevated levels of interleukin-4 and reduced levels of gamma interferonAbebech Demissie, Liya Wassie, Markos Abebe, et al.
Journal of Clinical Microbiology|February 5, 2002
Immune responses to the Mycobacterium tuberculosis-specific antigen ESAT-6 signal subclinical infection among contacts of tuberculosis patientsT Mark Doherty, Abebech Demissie, Joseph Olobo, et al.
The Lancet. Infectious Diseases|February 28, 2009
Biomarkers for tuberculosis disease activity, cure, and relapseRobert S Wallis, T Mark Doherty, Phillip Onyebujoh, et al.
Human Vaccines|December 24, 2010
First in humans: a new molecularly defined vaccine shows excellent safety and strong induction of long-lived Mycobacterium tuberculosis-specific Th1-cell like responsesTom H M Ottenhoff, T Mark Doherty, Jaap T van Dissel, et al.
Plos One|August 23, 2012
Risk stratification of latent tuberculosis defined by combined interferon gamma release assaysVéronique Corbière, Gaelle Pottier, Florence Bonkain, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 24, 2002
Mycobacterium avium complex promotes recruitment of monocyte hosts for HIV-1 and bacteriaHollie Hale-Donze, Teresa Greenwell-Wild, Diane Mizel, et al.
The Lancet. Infectious Diseases|February 2, 2010
Biomarkers for tuberculosis disease activity, cure, and relapseRobert S Wallis, Cunshan Wang, T Mark Doherty, et al.
NPJ Aging and Mechanisms of Disease|December 30, 2017
Fighting against a protean enemy: immunosenescence, vaccines, and healthy agingGiuseppe Del Giudice, Jörg J Goronzy, Beatrix Grubeck-Loebenstein, et al.
Pageof 10

Showing results (41-50 of 91) with videos related to

Sort By:
Pageof 10
Vaccine|May 23, 2009
Vaccines in a hurryChristian Søborg, Kåre Mølbak, T Mark Doherty, et al.
Lancet (London, England)|May 22, 2010
Biomarkers and diagnostics for tuberculosis: progress, needs, and translation into practiceRobert S Wallis, Madhukar Pai, Dick Menzies, et al.
Infection and Immunity|April 20, 2006
The 6-kilodalton early secreted antigenic target-responsive, asymptomatic contacts of tuberculosis patients express elevated levels of interleukin-4 and reduced levels of gamma interferonAbebech Demissie, Liya Wassie, Markos Abebe, et al.
Journal of Clinical Microbiology|February 5, 2002
Immune responses to the Mycobacterium tuberculosis-specific antigen ESAT-6 signal subclinical infection among contacts of tuberculosis patientsT Mark Doherty, Abebech Demissie, Joseph Olobo, et al.
The Lancet. Infectious Diseases|February 28, 2009
Biomarkers for tuberculosis disease activity, cure, and relapseRobert S Wallis, T Mark Doherty, Phillip Onyebujoh, et al.
Human Vaccines|December 24, 2010
First in humans: a new molecularly defined vaccine shows excellent safety and strong induction of long-lived Mycobacterium tuberculosis-specific Th1-cell like responsesTom H M Ottenhoff, T Mark Doherty, Jaap T van Dissel, et al.
Plos One|August 23, 2012
Risk stratification of latent tuberculosis defined by combined interferon gamma release assaysVéronique Corbière, Gaelle Pottier, Florence Bonkain, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 24, 2002
Mycobacterium avium complex promotes recruitment of monocyte hosts for HIV-1 and bacteriaHollie Hale-Donze, Teresa Greenwell-Wild, Diane Mizel, et al.
The Lancet. Infectious Diseases|February 2, 2010
Biomarkers for tuberculosis disease activity, cure, and relapseRobert S Wallis, Cunshan Wang, T Mark Doherty, et al.
NPJ Aging and Mechanisms of Disease|December 30, 2017
Fighting against a protean enemy: immunosenescence, vaccines, and healthy agingGiuseppe Del Giudice, Jörg J Goronzy, Beatrix Grubeck-Loebenstein, et al.
Pageof 10